A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-
Shoji Kudoh, MD
Advertisement
Articles by Shoji Kudoh, MD
Advertisement
Latest Updated Articles
- UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Issues CRL for Dasatinib in CML/ALL
2
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
3
FDA Accepts Resubmission of BLA for RP1/Nivolumab in Advanced Melanoma
4
Oral SERD Regimen May Prolong Efficacy in Second-Line Breast Cancer Care
5
